Quality of life in kids after MIS-C
Part of Heart & circulation, Immune system & allergy, Infections clinical trials.
This study looks at how children feel and live their daily lives after recovering from MIS-C (a severe inflammatory condition linked to COVID-19). It compares them to healthy children of the same age and gender to see if there are any lasting effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have had MIS-C (a rare inflammatory condition after COVID-19).
- Your child must be similar in age and gender to another child in the study who had MIS-C.
- Your child must not have any long-term health problems (like asthma, diabetes, or epilepsy) or lasting physical disabilities (like hearing loss or cerebral palsy).
- Your child must not have been hospitalized for any other reason in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the heart health of children and teens who had MIS-C (a rare inflammatory condition linked to COVID-19) about 5 years later. It will compare their results to those of healthy children, to see if there are any lasting effects on the heart.
This study looks at what long-term health effects children may have after getting COVID-19, and how those effects change over time. You may be asked to share health information and possibly complete a scan that can’t be done if certain metal is present.
This trial is studying children who are very sick from COVID-19 or have a related condition called MIS-C. It aims to understand how severe COVID-19 affects children and improve care.
This study looks at brain and nerve problems in children and teens who had COVID-19. It uses brain scans and other tests to understand long-lasting symptoms like headaches, tiredness, memory issues, or dizziness.
This study looks at how long “long COVID” affects children over time. It may help doctors better understand what symptoms last and what support could improve recovery.
This study is tracking children, teens, and young adults (up to age 25) who developed ME/CFS after an infection. It aims to better understand the condition in younger people.
Hear when a new Multisystem Inflammatory Syndrome in Children (MIS-C) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.